AZTR — Azitra, Inc. catalysts
Next verified catalyst
2027-01-15 — A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-15 in 4mo
ESTIMATED |
READOUT
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
Phase 1/2 · EGFR Inhibitor-associated Rash |
AZTR Azitra, Inc. | ATR04-484, Vehicle |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
|